It has been demonstrated in preclinical studies that the enhanced activity of HGF/c-MET can activate the proliferation of melanoma cells [82], increase their invasive capacity [78,83,84,85], and protect melanoma cells from apoptosis [73]. This evidence concerns the gene HGF and melanoma.